FASLG and lymphoma: Acquired or inherited genetic variants leading to defects in the classic Fas-Fas ligand pathway result in abnormal lymphocyte survival, causing benign and chronic (more than 6 months) non-infectious lymphoproliferation, autoimmunity, and increased lymphoma risk .47